| A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation. | |
| | |
MedLine Citation:
|
PMID: 22577119 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Background: Multiple sclerosis (MS) patients discontinuing natalizumab treatment are at risk of disease reactivation. No clinical or surrogate parameters exist to identify patients at risk of post-natalizumab MS reactivation.Objective: To determine the role of natalizumab-induced lymphocytosis and of Akt polymorphisms in disease reactivation after natalizumab discontinuation.Methods: Peripheral leukocyte count and composition were monitored in 93 MS patients during natalizumab treatment, and in 56 of these subjects who discontinued the treatment. Genetic variants of the anti-apoptotic protein Akt were determined in all subjects because natalizumab modulates the apoptotic pathway and lymphocyte survival is regulated by the apoptotic cascade.Results: Natalizumab-induced peripheral lymphocytosis protected from post-natalizumab MS reactivation. Subjects who relapsed or had magnetic resonance imaging (MRI) worsening after treatment cessation, in fact, had milder peripheral lymphocyte increases during the treatment, largely caused by less marked T cell increase. Furthermore, subjects carrying a variant of the gene coding for Akt associated with reduced anti-apoptotic efficiency (rs2498804T) had lower lymphocytosis and higher risk of disease reactivation.Conclusion: This study identified one functionally meaningful genetic variant within the Akt signaling pathway that is associated with both lymphocyte count and composition alterations during natalizumab treatment, and with the risk of disease reactivation after natalizumab discontinuation. |
| | |
Authors:
|
Silvia Rossi; Caterina Motta; Valeria Studer; Fabrizia Monteleone; Valentina De Chiara; Fabio Buttari; Francesca Barbieri; Giorgio Bernardi; Luca Battistini; Gary Cutter; Olaf Stüve; Marco Salvetti; Diego Centonze |
Related Documents
:
|
22816379 - Multiple low-dose infusions of human umbilical cord blood cells improve cognitive impai... 12781709 - Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease. 1514469 - Diagnosis and treatment of croup. 9391959 - Upper respiratory tract disease and mycoplasmosis in desert tortoises from nevada. 22822399 - Alzheimer's disease, neuroprotection, and cns immunosenescence. 14711339 - Mucosal immunization against respiratory bacterial pathogens. 10335769 - Evidence that anticardiolipin antibodies are independent risk factors for atherosclerot... 8274799 - Keratosis extremitatum (greither's disease): clinical features, histology, ultrastructure. 23186899 - Vascular diseases of the spinal cord. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-5-10 |
Journal Detail:
|
Title: Multiple sclerosis (Houndmills, Basingstoke, England) Volume: - ISSN: 1477-0970 ISO Abbreviation: - Publication Date: 2012 May |
Date Detail:
|
Created Date: 2012-5-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9509185 Medline TA: Mult Scler Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
1Clinica Neurologica, Università Tor Vergata, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dilator method and needle method for atrial transseptal puncture: a retrospective study from a cohor...
Next Document: Clostridium difficile: Epidemiology, Pathogenesis, Management, and Prevention of a Recalcitrant Heal...